Background illustration for clinical trials search

Paid Clinical Trials Rockville

Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

for
Hematologic Malignancies,
Location: Baltimore MD, Hackensack NJ, Chapel Hill NC, Detroit MI,
Sponsor: Pulmotect, Inc.

Sex: All

Age: 18+

Code: NCT06665100

Phase2, Recruiting

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

for
Chondral Defect, Osteochondritis Dissecans (OCD),
Location: Baltimore MD, Philadelphia PA, Akron OH, Columbus OH,
Sponsor: Vericel Corporation

Sex: All

Age: 10 - 17

Code: NCT03588975

Phase3, Recruiting

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

for
Pancreatic Cancer
Location: Baltimore MD, Millburn NJ, Lake Success NY,
Sponsor: University of Louisville

Sex: All

Age: 18+

Code: NCT02674100

Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: Chevy Chase MD, Harrisburg PA, Richmond VA,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase3, Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

for
Metastatic Dedifferentiated Liposarcoma,
Location: Bethesda MD, Baltimore MD, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05711615

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD, Pittsburgh PA, Trumbull CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691491

Phase1, Phase2, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Bethesda MD, Washington D.C. DC, Falls Church VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia,
Location: Baltimore MD, New York NY, Providence RI, Boston MA,
Sponsor: Imugene Limited

Sex: All

Age: 18+

Code: NCT03666000

Phase1, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Baltimore MD, Philadelphia PA, Boston MA, Nashville TN,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 2 - 65

Code: NCT06430385

Phase1, Phase2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Neptune City NJ, Washington D.C. DC, Vienna VA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

for
Metastatic Malignant Solid Neoplasm,
Location: Bethesda MD, New York NY, Mineola NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687110

Phase1, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Bethesda MD, Fairfax VA, Falls Church VA,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

for
Advanced Alveolar Soft Part Sarcoma,
Location: Bethesda MD, Pittsburgh PA, Trumbull CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05333458

Phase2, Recruiting

Distal Radius Interventions for Fracture Treatment

for
Fracture Distal Radius
Location: Baltimore MD, Wilmington DE, Philadelphia PA,
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: All

Age: 4 - 10

Code: NCT05131685

Recruiting

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD, New York NY, Mineola NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687136

Phase1, Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for
Adult Acute Myeloid Leukemia
Location: Baltimore MD, Rochester NY, Cleveland OH, Detroit MI,
Sponsor: Priothera SAS

Sex: All

Age: 18 - 70+

Code: NCT05429632

Phase3, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Baltimore MD, Richmond VA, Philadelphia PA, Danville PA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase2, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Baltimore MD, Fredericksburg VA, Allentown PA,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

for
Delirium
Location: Baltimore MD, New York NY, The Bronx NY, Durham NC,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 60+

Code: NCT06192615

Phase3, Recruiting